🇺🇸 plasmapheresis in United States

71 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective For Unapproved Indication — 11 reports (15.49%)
  2. Pyrexia — 10 reports (14.08%)
  3. Transplant Rejection — 10 reports (14.08%)
  4. Off Label Use — 8 reports (11.27%)
  5. Hypoxia — 6 reports (8.45%)
  6. Sepsis — 6 reports (8.45%)
  7. Anaemia — 5 reports (7.04%)
  8. Blood Creatinine Increased — 5 reports (7.04%)
  9. Drug Ineffective — 5 reports (7.04%)
  10. Dyspnoea — 5 reports (7.04%)

Source database →

Other Other approved in United States

Frequently asked questions

Is plasmapheresis approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for plasmapheresis in United States?

University of Cincinnati is the originator. The local marketing authorisation holder may differ — check the official source linked above.